Marshall Wace, LLP Pulse Biosciences, Inc. Call Options Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLSE
# of Institutions
67Shares Held
4.72MCall Options Held
239KPut Options Held
94.2K-
Black Rock Inc. New York, NY1.04MShares$11.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA847KShares$9.48 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC780KShares$8.72 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA391KShares$4.37 Million0.0% of portfolio
-
State Street Corp Boston, MA350KShares$3.91 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $415M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...